Octreotide is not useful for clomiphene citrate resistance in patients with polycystic ovary syndrome but may reduce the likelihood of ovarian hyperstimulation syndrome-Reference-Cited by-同舟云学术

Octreotide is not useful for clomiphene citrate resistance in patients with polycystic ovary syndrome but may reduce the likelihood of ovarian hyperstimulation syndrome

Published:1999-03 Issue:3 Volume:71 Page:452-456
ISSN:0015-0282
Container-title:Fertility and Sterility
language:en
Short-container-title:Fertility and Sterility

Author:

Morris Randy S,Karande Vishvanath C,Dudkiewicz Alan,Morris Jody L,Gleicher Norbert

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Reproductive Medicine

Reference20 articles.

1. Metabolic parameters that predict response to clomiphene citrate in obese oligo-ovulatory women;Armstrong;Mil Med,1996

2. Serum levels of insulin-like growth factor binding protein-1 and ovulatory responses to clomiphene citrate in women with polycystic ovarian disease;Tiitinen;Fertil Steril,1993

3. The impact of insulin secretion on the ovarian response to exogenous gonadotropins in polycystic ovary syndrome;Fulghesu;J Clin Endocrinol Metab,1997

4. Potential indications for octreotide in endocrinology;Von Werder;Metabolism,1992

5. Ovarian hyperstimulation;Golan;Obstet Gynecol Surv,1989

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estrogens and selective estrogen receptor modulators in acromegaly;Endocrine;2016-10-04

2. Management strategies for ovulation induction in women with polycystic ovary syndrome and known clomifene citrate resistance;Current Opinion in Obstetrics & Gynecology;2009-12

3. Insulin-sensitizing agents in polycystic ovary syndrome;European Journal of Endocrinology;2006-06

4. Efficacy of Octreotide-LAR in Dieting Women with Abdominal Obesity and Polycystic Ovary Syndrome;The Journal of Clinical Endocrinology & Metabolism;2005-07-01

5. Insulin-Lowering Agents in the Management of Polycystic Ovary Syndrome;Endocrine Reviews;2003-10-01